Serum complement C3c concentration in non-obese young insulin-resistant Mexicans

Area of Science:

• Immunology
• Metabolic Health
• Human Physiology

Background:

• Insulin resistance is a growing health concern, particularly in non-obese young adults.
• Complement system, including C3, plays a role in inflammation and metabolic processes.
• Understanding C3 levels in relation to insulin sensitivity is crucial for early detection and intervention.

Purpose of the Study:

• To compare serum complement C3 concentrations between insulin-sensitive and insulin-resistant non-obese young Mexican men.
• To investigate potential correlations between serum C3 levels and markers of insulin resistance, glucose metabolism, and lipid profiles.

Main Methods:

• Cross-sectional study involving 28 healthy, non-obese (BMI < 26 kg/m2) male volunteers aged 19-25 years.
• Insulin sensitivity assessed using the insulin tolerance test (ITT) and calculating the constant for rate serum glucose disappearance (KITT).
• Serum C3c concentration measured via nephelometry; lipid profile and uric acid analyzed using enzymatic techniques.

Main Results:

• Serum C3 concentrations were statistically similar between insulin-resistant and insulin-sensitive groups (1.4 ± 0.2 vs 1.3 ± 0.1 g/l, p = 0.949).
• No significant correlations were observed between serum C3 concentrations and serum glucose, insulin levels, KITT, or lipid profiles.
• Biochemical characteristics, including lipid profile and uric acid, were measured but did not reveal significant associations with C3 levels in this cohort.

Conclusions:

• Serum complement C3c concentrations do not differ between non-obese young insulin-sensitive and insulin-resistant Mexican men.
• Insulin resistance in this specific demographic does not appear to be associated with altered serum C3 levels.
• Further research may explore other complement components or different populations to elucidate the role of the complement system in insulin resistance.